RhumbLine Advisers
FURX

RhumbLine Advisers’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

RhumbLine Advisers’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-7,237
Closed -$768K – 3024
2014
Q2 		$768K Sell
7,237
-133
-2% -$13K ﹤0.01% 2003
2014
Q1 		$641K Sell
7,370
-506
-6% -$39.1K ﹤0.01% 2059
2013
Q4 		$331K Hold
7,876
– – ﹤0.01% 2525
2013
Q3 		$346K Sell
7,876
-67
-0.8% -$2.77K ﹤0.01% 2436
2013
Q2 		$271K Buy
+7,943
New +$279K ﹤0.01% 2741

RhumbLine Advisers's FURX Position: Q3 2014 in Review

RhumbLine Advisers sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 7,237 shares — an estimated $768K sold.

RhumbLine Advisers first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $768K in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • RhumbLine Advisers reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • RhumbLine Advisers sold 7,237 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $768K.
  • RhumbLine Advisers first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • RhumbLine Advisers's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $768K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on RhumbLine Advisers's 13F filing for Q3 2014, filed 12 Nov 2014.